Wells Fargo’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.27M | Buy |
2,071,524
+78,187
| +4% | +$250K | ﹤0.01% | 2282 |
|
|
2025
Q4 | $5.44M | Buy |
1,993,337
+475,973
| +31% | +$1.1M | ﹤0.01% | 2599 |
|
|
2025
Q3 | $3.29M | Buy |
1,517,364
+443,114
| +41% | +$1.05M | ﹤0.01% | 2924 |
|
|
2025
Q2 | $1.85M | Buy |
1,074,250
+215,680
| +25% | +$537K | ﹤0.01% | 3274 |
|
|
2025
Q1 | $2.86M | Buy |
858,570
+278,325
| +48% | +$1.44M | ﹤0.01% | 2877 |
|
|
2024
Q4 | $4.29M | Buy |
580,245
+4,401
| +0.8% | +$40.8K | ﹤0.01% | 2557 |
|
|
2024
Q3 | $5.41M | Buy |
575,844
+79,448
| +16% | +$753K | ﹤0.01% | 2289 |
|
|
2024
Q2 | $3.98M | Buy |
496,396
+128,609
| +35% | +$1.38M | ﹤0.01% | 2432 |
|
|
2024
Q1 | $5.45M | Buy |
367,787
+20,059
| +6% | +$233K | ﹤0.01% | 2194 |
|
|
2023
Q4 | $2.83M | Sell |
347,728
-185,441
| -35% | -$970K | ﹤0.01% | 2625 |
|
|
2023
Q3 | $2.43M | Buy |
533,169
+155,199
| +41% | +$1.01M | ﹤0.01% | 2649 |
|
|
2023
Q2 | $2.66M | Buy |
377,970
+130,053
| +52% | +$931K | ﹤0.01% | 2658 |
|
|
2023
Q1 | $1.51M | Buy |
247,917
+210,126
| +556% | +$1.45M | ﹤0.01% | 3085 |
|
|
2022
Q4 | $241K | Sell |
37,791
-20,529
| -35% | -$160K | ﹤0.01% | 4080 |
|
|
2022
Q3 | $558K | Buy |
58,320
+30,471
| +109% | +$351K | ﹤0.01% | 3628 |
|
|
2022
Q2 | $308K | Sell |
27,849
-24,277
| -47% | -$318K | ﹤0.01% | 4045 |
|
|
2022
Q1 | $868K | Sell |
52,126
-3,796
| -7% | -$58.7K | ﹤0.01% | 4011 |
|
|
2021
Q4 | $1.07M | Buy |
55,922
+6,528
| +13% | +$144K | ﹤0.01% | 4048 |
|
|
2021
Q3 | $1.22M | Sell |
49,394
-6,172
| -11% | -$145K | ﹤0.01% | 4075 |
|
|
2021
Q2 | $1.45M | Sell |
55,566
-5,188
| -9% | -$135K | ﹤0.01% | 3961 |
|
|
2021
Q1 | $1.92M | Sell |
60,754
-11,486
| -16% | -$476K | ﹤0.01% | 3734 |
|
|
2020
Q4 | $3.35M | Sell |
72,240
-44,567
| -38% | -$1.77M | ﹤0.01% | 3086 |
|
|
2020
Q3 | $3.85M | Sell |
116,807
-46,756
| -29% | -$1.43M | ﹤0.01% | 2749 |
|
|
2020
Q2 | $4.49M | Buy |
163,563
+55,942
| +52% | +$1.84M | ﹤0.01% | 2560 |
|
|
2020
Q1 | $3.22M | Sell |
107,621
-100,893
| -48% | -$2.67M | ﹤0.01% | 2604 |
|
|
2019
Q4 | $5.77M | Buy |
208,514
+8,808
| +4% | +$200K | ﹤0.01% | 2427 |
|
|
2019
Q3 | $3.63M | Buy |
199,706
+12,455
| +7% | +$275K | ﹤0.01% | 2828 |
|
|
2019
Q2 | $4.59M | Sell |
187,251
-187,466
| -50% | -$2.82M | ﹤0.01% | 2645 |
|
|
2019
Q1 | $3.56M | Buy |
374,717
+134,831
| +56% | +$1.31M | ﹤0.01% | 2865 |
|
|
2018
Q4 | $2.12M | Buy |
239,886
+81,428
| +51% | +$785K | ﹤0.01% | 3215 |
|
|
2018
Q3 | $1.78M | Buy |
158,458
+75,671
| +91% | +$1.07M | ﹤0.01% | 3510 |
|
|
2018
Q2 | $1.06M | Buy |
82,787
+27,955
| +51% | +$409K | ﹤0.01% | 3957 |
|
|
2018
Q1 | $926K | Buy |
54,832
+4,957
| +10% | +$75.1K | ﹤0.01% | 3972 |
|
|
2017
Q4 | $398K | Sell |
49,875
-53,653
| -52% | -$431K | ﹤0.01% | 4551 |
|
|
2017
Q3 | $801K | Buy |
103,528
+31,724
| +44% | +$201K | ﹤0.01% | 3997 |
|
|
2017
Q2 | $528K | Buy |
71,804
+21,654
| +43% | +$138K | ﹤0.01% | 4187 |
|
|
2017
Q1 | $374K | Buy |
50,150
+12,000
| +31% | +$88K | ﹤0.01% | 4434 |
|
|
2016
Q4 | $265K | Buy |
38,150
+18,980
| +99% | +$131K | ﹤0.01% | 4608 |
|
|
2016
Q3 | $158K | Hold |
19,170
| – | – | ﹤0.01% | 4625 |
|
|
2016
Q2 | $155K | Sell |
19,170
-2,898
| -13% | -$18.2K | ﹤0.01% | 4550 |
|
|
2016
Q1 | $112K | Buy |
22,068
+2,727
| +14% | +$14.9K | ﹤0.01% | 4755 |
|
|
2015
Q4 | $149K | Sell |
19,341
-181,760
| -90% | -$1.26M | ﹤0.01% | 4643 |
|
|
2015
Q3 | $1.16M | Buy |
201,101
+198,847
| +8,822% | +$1.55M | ﹤0.01% | 3396 |
|
|
2015
Q2 | $21K | Buy |
+2,254
| New | +$25.2K | ﹤0.01% | 5581 |
|
Other funds holding IOVA
MFM
VCM
VPM
ICM